Improving Glycemic Control on GMS: A Quality Improvement Study

Diabetes Mellitus Clinical Trial

Official title:

Improving Glycemic Control on GMS: A Quality Improvement Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00271700
• Other study ID #: 2005-P-001880/1
• Secondary ID: 2005-P-001880/1
• Status: Completed
• Phase: N/A
• Start date: May 2010
• Est. completion date: March 2011

Study information

• Verified date: August 2019
• Source: Brigham and Women's Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will examine whether new processes and technologies for monitoring diabetic patients' insulin levels improves patient care at Brigham and Women's Hospital.

Description:

This study will examine whether new processed and technologies for monitoring diabetic patients' insulin levels improves patient care. Patients at Brigham and Women's Hospital (BWH), staying on the General Medicine Service, who have Type 2 diabetes and who are not on IV insulin can participate in this study. Physicians and nurses will be taught new rules to care for diabetic patients, while in the hospital. Also, the BWH computer system will be updated to include these new rules for administering insulin. Patients who participate in the study will be randomly placed into one of two groups: one group that will be cared for by physicians and nurses who have learned these new rules for administering insulin; or the second group, who will receive diabetes care at BWH before the new rules were adopted. The study will last approximately 1 year.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 179
• Est. completion date: March 2011
• Est. primary completion date: March 2011
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Subjects will include all type 2 diabetic patients on the General Medicine Service (GMS) of Brigham and Women's Hospital (BWH) who do not have an indication for IV insulin.

Exclusion Criteria:

• Type 2 diabetic patients on the General Medicine Service (GMS) of Brigham and Women's Hospital (BWH) who have an indication for IV insulin.

Related Conditions & MeSH terms

• Diabetes Mellitus

Intervention

Behavioral:
• Order Set, Education, Feedback

Locations

Country	Name	City	State
United States	Brigham and Women's Hospital	Boston	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Brigham and Women's Hospital	Novo Nordisk A/S

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	- Point-of-care testing glucose values (percent of routine glucose readings between 60 and 180 mg/dL)
Primary	- Lab glucose values (percent of routine glucose readings between 60 and 180 mg/dL)
Secondary	- Quality of insulin orders using explicit criteria